These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9008283)

  • 1. Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.
    Bass HZ; Fahey JL; Nishanian P; Detels R; Cumberland W; Kemeny M; Plaeger S
    Clin Diagn Lab Immunol; 1997 Jan; 4(1):64-9. PubMed ID: 9008283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.
    Bass HZ; Nishanian P; Hardy WD; Mitsuyasu RT; Esmail E; Cumberland W; Fahey JL
    Clin Immunol Immunopathol; 1992 Jul; 64(1):63-70. PubMed ID: 1376654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
    Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
    Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
    Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
    AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.
    Givens TS; DuChateau BK; Boomer JS; Westerman MP; Gilman-Sachs A; Beaman KD
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):872-7. PubMed ID: 10548579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation markers and AIDS prognosis.
    Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
    AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.
    Dybul M; Mercier G; Belson M; Hallahan CW; Liu S; Perry C; Herpin B; Ehler L; Davey RT; Metcalf JA; Mican JM; Seder RA; Fauci AS
    J Immunol; 2000 Aug; 165(3):1685-91. PubMed ID: 10903780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection.
    Vingerhoets J; Bisalinkumi E; Penne G; Colebunders R; Bosmans E; Kestens L; Vanham G
    Immunol Lett; 1998 Mar; 61(1):53-61. PubMed ID: 9562375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
    Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of functionality, immunophenotype, and recovery of HIV RNA from PBMCs cryopreserved for more than 20 years.
    Dyer WB; Suzuki K; Levert A; Starr M; Lloyd AR; Zaunders JJ
    Front Immunol; 2024; 15():1382711. PubMed ID: 39221258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.
    Sousa AE; Carneiro J; Meier-Schellersheim M; Grossman Z; Victorino RM
    J Immunol; 2002 Sep; 169(6):3400-6. PubMed ID: 12218162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and proliferation of CD8+ T cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor.
    Brinchmann JE; Røsok BI; Spurkland A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):332-8. PubMed ID: 9833741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.